Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Elevated Triglycerides Associated with Risk of PAD

By LabMedica International staff writers
Posted on 19 Sep 2018
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. Peripheral artery disease (PAD) is common, and although it is associated with cardiovascular (CV) morbidity, mortality, loss of quality of life and increased health care burden.

Data on PAD is relatively scarce compared with data on coronary artery disease. Elevated triglycerides (TG) are known to be associated with and to be a predictive factor for PAD; therefore, more data on elevated TG in PAD and peripheral arterial revascularization are needed.

Scientists at the University of Illinois College of Medicine (Peoria, IL, USA) and their colleagues carried out a retrospective administrative analysis of the Optum Research Database that includes more than 160 million individuals, and identified 1,646,031 individuals who filled at least one statin prescription in 2010 and had at least a 6-month follow-up. Of that group 390,632 individuals met criteria for inclusion in the study; the team was able to create 23,181 propensity score matched pairs.

The two groups included patients with triglyceride levels ≥150 mg/dL and a group of patients with triglycerides <150 mg/dL and well-controlled LDL cholesterol. At 5 years, the probability of peripheral arterial revascularization was 6.9% among patients with elevated triglyceride levels versus 4.9% in the comparator cohort. Controlling for patient characteristics, patients with elevated triglycerides had a 13.4% higher rate of occurrence of an inpatient hospital stay per unit time than the comparator cohort.

Peter P. Toth, MD, PhD, director of preventive cardiology and the senior author of the study, said, “In a multivariate analysis controlled for patient characteristics and comorbidities, the rate of occurrence of peripheral arterial revascularization per unit time was 37% higher in the elevated-triglyceride cohort versus the comparator cohort. Patients with elevated triglycerides and a history of diabetes and/or atherosclerotic coronary vascular disease represent a relatively large population that may be commonly encountered in clinical practice, and warrants further study.” The study was presented at the 2018 Congress of the European Society of Cardiology held August 25-28, 2018, in Munich, Germany.

Related Links:
University of Illinois College of Medicine


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Centromere B Assay
Centromere B Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.